End-of-day quote
Taiwan S.E.
03:30:00 24/05/2024 am IST
5-day change
1st Jan Change
25.55
TWD
0.00%
-2.11%
+1.79%
Prodigy Diabetes Care, LLC acquired unknown substantial stake in OK Biotech Co., Ltd..
April 16, 2013 at 09:30 am IST
Prodigy Diabetes Care, LLC acquired unknown substantial stake in OK Biotech Co., Ltd. (GTSM:4155) on April 16, 2013. In a related deal, OK Biotech Co., Ltd. acquired unknown minority stake in Prodigy Diabetes Care, LLC on April 16, 2013.
Prodigy Diabetes Care, LLC completed the acquisition of unknown substantial stake in OK Biotech Co., Ltd. (GTSM:4155) on April 16, 2013.
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
19/03
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
13/11
CI
OK Biotech Co., Ltd.(TWSE:4155) added to S&P Global BMI Index
18/23/18
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/23/14
CI
OK Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
29/23/29
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/22/14
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
12/22/12
CI
OK Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
12/22/12
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
01/22/01
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
12/21/12
CI
OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
17/21/17
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
14/21/14
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
31/21/31
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
12/20/12
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
12/20/12
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
13/20/13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
23/20/23
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
13/19/13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
13/19/13
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
14/19/14
CI
Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018
28/19/28
CI
OK Biotech Co., Ltd.(GTSM:4155) added to Taiwan TAIEX Index
14/18/14
CI
OK Biotech Co., Ltd. acquired unknown minority stake in Prodigy Diabetes Care, LLC.
16/13/16
CI
Prodigy Diabetes Care, LLC acquired unknown substantial stake in OK Biotech Co., Ltd..
16/13/16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
More about the company
1st Jan change
Capi.
+1.79% 116M +75.35% 12.54B -23.01% 7.39B +8.35% 6.62B +14.40% 5.43B +32.74% 4.81B -14.85% 4.8B -25.57% 3.72B -23.06% 2.76B +55.06% 2.4B
Medical Equipment
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1